SCHEMBL7079873

SCHEMBL7079873

CC(C)(C)OC(=O)ON1CCC(c2ccc(OCc3cc(-c4ccccc4)no3)cc2)C(OCc2ccc3ccccc3c2)C1

nearest known ligand 0.46

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
REN P00797 14/20 0.46
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MAPT P10636 1/20 0.39
PRMT5 O14744 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7082067 0.88 RAB9A (0.39) RENNPC1RAB9ASMN1; SMN2TDP1
SCHEMBL7079998 0.88 REN (0.62) RENNPC1RAB9ASMN1; SMN2TDP1
SCHEMBL6958396 0.86 RAB9A (0.45) NPC1RAB9ASMN1; SMN2TDP1L3MBTL1
SCHEMBL7080459 0.86 NPC1 (0.36) RENNPC1RAB9ASMN1; SMN2TDP1
SCHEMBL6043947 0.85 REN (0.50) RENNPC1RAB9ASMN1; SMN2TDP1
SCHEMBL7080924 0.85 REN (0.54) REN
SCHEMBL7076956 0.85 REN (0.41) RENNPC1RAB9ASMN1; SMN2TDP1
SCHEMBL7080921 0.85 REN (0.46) RENNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL7075237 0.84 REN (0.56) REN
SCHEMBL7074891 0.84 REN (0.48) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0863875-B1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY HOFFMANN LA ROCHE (CH) 2003-06-04 EP disclosed
EP-0863875-A1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY F. HOFFMANN-LA ROCHE AG (CH) 1998-09-16 EP disclosed
WO-1997009311-A1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY F. HOFFMANN-LA ROCHE AG (CH) 1997-03-13 WO disclosed